GB664262A - Manufacture of heterocyclically substituted diaminoquinazolines - Google Patents
Manufacture of heterocyclically substituted diaminoquinazolinesInfo
- Publication number
- GB664262A GB664262A GB3339/49A GB333949A GB664262A GB 664262 A GB664262 A GB 664262A GB 3339/49 A GB3339/49 A GB 3339/49A GB 333949 A GB333949 A GB 333949A GB 664262 A GB664262 A GB 664262A
- Authority
- GB
- United Kingdom
- Prior art keywords
- amino
- diethylamino
- quinazoline
- benzthiazole
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Heterocyclically - disubstituted quinazolines are prepared by treating a quinazoline having in the 2- or 4-position a halogen atom or a substituted hydroxy or mercapto group and in the other of these positions a substituted amino group wherein the substituent contains a tertiary amino group, with an amino compound, the amino group of which is directly bound to the carbon atom in the 2-position of a thiazole or imidazole ring; alternatively, the same products may be obtained by reacting an amino-substituted tertiary amine with the appropriate thiazoylamino- or imidazolylaminoquinazoline. The thiazole or imidazole ring may be present in the form of benzthiazole or benzimidazole and in general may have fusedon aromatic or heterocyclic nuclei. The products may contain alkyl, phenyl, nitro, amino, cyano, halogen or free or substituted hydroxyl substituents. The residue containing a tertiary amino group may be a straight or branched aliphatic residue (with or without interrupting heteroatoms such as oxygen and sulphur) or a carboxylic or aliphatic-carbocyclic residue containing as substituent a dialkylamino group, or a chain terminated by a cyclic group such as piperidino or morpholino. The reaction may be carried out in the presence or absence of a diluent, an acid-binding agent, a condensing agent or a catalyst. The products (if obtained as free bases) may be converted into salts with acids such as hydrochloric, sulphuric, phosphoric, methane sulphonic, toluene sulphonic, acetic, oxalic and citric acids. Nitro groups in the products may be reduced to amino groups. Many examples are given, the residues being those of (1) quinoxaline and 6 - chloro - quinoxaline; (2) 2 - amino - benzthiazole, 2 - amino - 4 - methyl - benzthiazole, 2 - amino - 6 - methyl - benzthiazole, 2 - amino - 6 - chloro - benzthiazole, 2 - amino - 6 - methoxy - benzthiazole, 2 - amino - 4 : 7 - dimethyl - benzthiazole, 2 - amino - 6 - nitro - benzthiazole, 2 - amino - 6 - cyano - benzthiazole, 2 - amino - 6 - n - butoxy - benzthiazole, 2 - amino - 6 - acetamino - benzthiazole, 2 - amino - naphthothiazole, 2-amino-thiazole, 2-amino-4-phenylthiazole, 2 - amino - 4 - p - bromophenyl - thiazole, 2 - amino - 4 : 5 - diphenyl - thiazole and 2 - amino - benzimidazole; (3) b - diethylamino - ethylamine, g - diethylamino - propylamine, N - (b - diethylamino - ethyl) - aniline, 1 - diethylamino - 3 - amino - butane, b - piperidino - ethylamine and p - (b - diethylamino - ethoxy)-aniline. The starting materials are obtained by reacting a quinazoline substituted in the 2- and 4-positions by exchangeable groups (e.g. 2 : 4-dichloroquinazoline, 2-chloro-4-hydroxy-quinazoline) with the appropriate amine. Compounds thus prepared are 2-chloro-4-[N-phenyl-N - (b - diethylamino - ethyl) - amino - ] quinazoline, 2 - [61 - methyl - benzthiazolyl - 21 - amino] - 4 - hydroxy - quinazoline (converted into the 4-chloro-compound with phosphorus oxychloride), 2-(b -diethylamino-ethylamino)-4-hydroxy-quinazoline (converted into the 4-chloro-compound with phosphorus oxychloride), 2 - chloro - 4 - [p - (b - diethylamino - ethoxy) - anilino] - quinazoline and 2 - chloro - 4 - [11 - diethylamino - butyl - 31 - amino] - quinazoline. 2 - Amino - 4 : 7 - dimethyl - benzthiazole is obtained from 2 : 5-dimethyl-phenyl-thiourea by normal methods. 2 - Methoxy - 4 - (b - diethylamino - ethylamino)-quinazoline is obtained from the 2-chloro-compound and sodium methoxide. Samples have been furnished under Sect. 2 (5) of (1) 2-[41-p-tolyl-thiazolyl-21-amino]-4-(b -diethylamino -ethylamino)-quinazoline prepared from 2 - amino - 4 - p - tolyl - thiazole and 2 - chloro - 4 - (b - diethylamino - ethylamino) - quinazoline; and (2) 2-[61-methyl-benzthiazolyl-21 - amino] - 4 - [b - (b 1 - diethylamino - ethylthio) - ethylamino] - quinazoline prepared by reacting 2 : 4-dichloro-quinazoline with b -amino-b 1 - diethylamino - diethyl sulphide and treating the resulting 2-chloro-4-[b -(b 1-diethylaminoethylthio) - ethylamino] - quinazoline with 2 - amino-6-methyl-benzthiazole. The Specification as open to inspection under Sect. 91 refers to compounds containing in place of the tertiary amino group any strongly basic group, e.g. primary or secondary amino. It also mentions compounds containing mercapto substituents. The attachment to the thiazole or imidazole ring is not limited to the 2-position. This subject-matter does not appear in the Specification as accepted.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH664262X | 1948-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB664262A true GB664262A (en) | 1952-01-02 |
Family
ID=4527159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3339/49A Expired GB664262A (en) | 1948-02-09 | 1949-02-07 | Manufacture of heterocyclically substituted diaminoquinazolines |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE487239A (en) |
CH (3) | CH276269A (en) |
FR (1) | FR980225A (en) |
GB (1) | GB664262A (en) |
NL (1) | NL70218C (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1404337A2 (en) * | 2001-06-19 | 2004-04-07 | Bristol-Myers Squibb Company | QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
US7320989B2 (en) * | 2003-02-28 | 2008-01-22 | Encysive Pharmaceuticals, Inc. | Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040033986A1 (en) * | 2002-05-17 | 2004-02-19 | Protopopova Marina Nikolaevna | Anti tubercular drug: compositions and methods |
-
0
- NL NL70218D patent/NL70218C/xx active
- BE BE487239D patent/BE487239A/xx unknown
-
1948
- 1948-02-09 CH CH276269D patent/CH276269A/en unknown
- 1948-02-09 CH CH279190D patent/CH279190A/en unknown
-
1949
- 1949-01-12 CH CH282950D patent/CH282950A/en unknown
- 1949-02-07 GB GB3339/49A patent/GB664262A/en not_active Expired
- 1949-02-07 FR FR980225D patent/FR980225A/en not_active Expired
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1404337A2 (en) * | 2001-06-19 | 2004-04-07 | Bristol-Myers Squibb Company | QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
EP1404337A4 (en) * | 2001-06-19 | 2006-04-12 | Bristol Myers Squibb Co | QUINAZOLINE AND PYRIDO 2,3-d|PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
US7601836B2 (en) | 2001-06-19 | 2009-10-13 | Bristol-Myers Squibb Company | Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
US7320989B2 (en) * | 2003-02-28 | 2008-01-22 | Encysive Pharmaceuticals, Inc. | Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
Also Published As
Publication number | Publication date |
---|---|
FR980225A (en) | 1951-05-09 |
CH276269A (en) | 1951-06-30 |
NL70218C (en) | |
BE487239A (en) | |
CH279190A (en) | 1951-11-15 |
CH282950A (en) | 1952-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1976847B1 (en) | Pyrimidinyl aryl urea derivatives being fgf inhibitors | |
AU2005256491C1 (en) | Pyrimidine urea derivatives as kinase inhibitors | |
JP4828421B2 (en) | Quinazoline derivatives as receptor tyrosine kinase inhibitors | |
US2846397A (en) | Water-soluble salts of derivatives of 4:4'-diaminostilbene-2:2'-disulfonic acid for enhancing the brightness of organic fibrous material | |
IL154514A (en) | Quinazoline derivatives and pharmaceutical compositions containing the same | |
ATE40684T1 (en) | (BENZOYL-4-PIPERIDINO)-2-PHENYL-1ALKANOL DERIVATIVES, THEIR PRODUCTION AND USE AS MEDICINES. | |
PT77735B (en) | PROCESS FOR THE PREPARATION OF BENZOXAZOLINONE DERIVATIVES | |
EP0318225A2 (en) | 6-Aryl aminomethyl quinoline derivatives and their use as anti-tumour agents | |
US2485212A (en) | 2-[phenthiazinyl-(n)-methyl]-imidazolines, the corresponding 2-(phenoxazinyl) imidazolines, and their salts | |
SG172229A1 (en) | Thiazolyl-benzimidazoles | |
GB664262A (en) | Manufacture of heterocyclically substituted diaminoquinazolines | |
JP2021510704A (en) | 5- (Pyrimidine-4-yl) thiazole-2-ylurea derivative as a therapeutic agent | |
GB832400A (en) | New anthraquinonoid dyestuffs | |
US2248356A (en) | Method of preparing aminated esters | |
US2488379A (en) | Quinazoline derivatives | |
Kelarev et al. | Synthesis and Properties of sym-Triazine Derivatives. 18. Synthesis of N-Substituted 2, 4-Diamino-6-(benzothiazolyl-2-thiomethyl)-sym-triazines | |
NZ209707A (en) | Sulphenamide derivatives and pharmaceutical compositions | |
ES530878A0 (en) | A PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF AMINOETICPIRIDINA OR PIRAZINA. | |
SU1355128A3 (en) | Method of producing piperazine-containing derivatives of alkylthiol or alkylthiocarbamate,or salts thereof | |
US2952687A (en) | Certain n- | |
US2692881A (en) | Benzothiazole derivatives | |
Penchev et al. | Preparation of 2-(N-alkyl-N-arylamino) ethyl trimethylammonium salts | |
GB662798A (en) | Improvements in or relating to the production of sulphonamides and intermediates thereof | |
PL97545B1 (en) | METHOD OF MAKING NEW DERIVATIVES OF OXAZOLIDIN | |
GB939822A (en) | Piperazine compounds |